Schonfeld Strategic Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $195K | Sell |
|
|||||
|
2024
Q4 | $327K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $38.8K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.85M | Sell |
|
|||||
|
2023
Q2 | $4.71M | Sell |
|
|||||
|
2023
Q1 | $4.61M | Buy |
|
|||||
|
2022
Q4 | $6.49M | Buy |
|
|||||
|
2022
Q3 | $6.3M | Sell |
|
|||||
|
2022
Q2 | $6.09M | Sell |
|
|||||
|
2022
Q1 | $8.15M | Sell |
|
|||||
|
2021
Q4 | $7.13M | Sell |
|
|||||
|
2021
Q3 | $9.23M | Buy |
|
|||||
|
2021
Q2 | $4.47M | Sell |
|
|||||
|
2021
Q1 | $9.26M | Buy |
|
|||||
|
2020
Q4 | $1.99M | Buy |
|
|||||
|
2020
Q3 | $641K | Buy |
|
|||||
|
2020
Q2 | $318K | Buy |
|
|||||
|
2020
Q1 | $23K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $944K | Sell |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2018
Q1 | $804K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.08M | Sell |
|
|||||
|
2017
Q1 | $1.44M | Buy |
|